- Home
- CPSH vs OTLK Comparison
CPSH vs OTLK Comparison
Compare CPSH & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPSH
- OTLK
- Stock Information
- Founded
- CPSH 1984
- OTLK 2010
- Country
- CPSH United States
- OTLK United States
- Employees
- CPSH N/A
- OTLK N/A
- Industry
- CPSH Building Materials
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPSH Consumer Discretionary
- OTLK Health Care
- Exchange
- CPSH Nasdaq
- OTLK Nasdaq
- Market Cap
- CPSH 51.9M
- OTLK 42.8M
- IPO Year
- CPSH 1987
- OTLK 2016
- Fundamental
- Price
- CPSH $3.32
- OTLK $1.20
- Analyst Decision
- CPSH
- OTLK Buy
- Analyst Count
- CPSH 0
- OTLK 5
- Target Price
- CPSH N/A
- OTLK $5.25
- AVG Volume (30 Days)
- CPSH 765.4K
- OTLK 1.3M
- Earning Date
- CPSH 10-29-2025
- OTLK 08-14-2025
- Dividend Yield
- CPSH N/A
- OTLK N/A
- EPS Growth
- CPSH N/A
- OTLK N/A
- EPS
- CPSH N/A
- OTLK N/A
- Revenue
- CPSH $30,321,555.00
- OTLK $1,505,322.00
- Revenue This Year
- CPSH N/A
- OTLK N/A
- Revenue Next Year
- CPSH N/A
- OTLK $342.80
- P/E Ratio
- CPSH N/A
- OTLK N/A
- Revenue Growth
- CPSH 38.22
- OTLK N/A
- 52 Week Low
- CPSH $1.39
- OTLK $0.79
- 52 Week High
- CPSH $4.89
- OTLK $6.98
- Technical
- Relative Strength Index (RSI)
- CPSH 40.93
- OTLK 44.94
- Support Level
- CPSH $3.33
- OTLK $1.28
- Resistance Level
- CPSH $3.69
- OTLK $1.31
- Average True Range (ATR)
- CPSH 0.33
- OTLK 0.09
- MACD
- CPSH -0.10
- OTLK -0.01
- Stochastic Oscillator
- CPSH 2.18
- OTLK 12.50
About CPSH CPS Technologies Corp.
CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.